Ericka M. Ebot
Impact in
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 11
- Prostate Cancer Diagnosis and Treatment 4
-
- Cancer, Lipids, and Metabolism 10
- Co-authors
- Lorelei A. Mucci (27 shared papers)Kathryn M. Wilson (13 shared papers)Claire H. Pernar (9 shared papers)Massimo Loda (18 shared papers)Edward L. Giovannucci (16 shared papers)Travis Gerke (11 shared papers)Tamara L. Lotan (8 shared papers)Jennifer R. Rider (9 shared papers)
- Journals
- Cancer Epidemiology Biomarkers & Prevention (4 papers)Clinical Cancer Research (3 papers)European Urology (2 papers)Carcinogenesis (2 papers)Prostate Cancer and Prostatic Diseases (2 papers)
- Partner nations
- United StatesSwedenIreland
In The Last Decade
Ericka M. Ebot
34 papers receiving 1.2k citations
Ericka M. Ebot's Hit Papers
Peers
Comparison fields: 5 of 94
- Cancer Research 303
- Pulmonary and Respiratory Medicine 472
- Oncology 237
- Molecular Biology 341
- Applied Microbiology and Biotechnology 7
Countries citing papers authored by Ericka M. Ebot
This map shows the geographic impact of Ericka M. Ebot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ericka M. Ebot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ericka M. Ebot more than expected).
Fields of papers citing papers by Ericka M. Ebot
This network shows the impact of papers produced by Ericka M. Ebot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ericka M. Ebot. The network helps show where Ericka M. Ebot may publish in the future.
Co-authors
The 25 scholars most cited alongside Ericka M. Ebot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Epidemiology of Prostate Cancer Hit paper breakdown → | 2018 | 557 |
| 2 | 2015 | 141 | |
| 3 | 2023 | 84 | |
| 4 | 2020 | 51 | |
| 5 | 2016 | 46 | |
| 6 | 2019 | 44 | |
| 7 | 2014 | 36 | |
| 8 | 2018 | 32 | |
| 9 | 2016 | 26 | |
| 10 | 2021 | 23 | |
| 11 | 2017 | 20 | |
| 12 | 2018 | 19 | |
| 13 | 2022 | 16 | |
| 14 | 2023 | 14 | |
| 15 | 2021 | 14 | |
| 16 | 2023 | 12 | |
| 17 | 2020 | 12 | |
| 18 | 2019 | 12 | |
| 19 | 2017 | 10 | |
| 20 | 2024 | 8 |
About Ericka M. Ebot
Ericka M. Ebot is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Molecular Biology and Genetics, having authored 37 papers that have together received 1.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (11 papers), Cancer, Lipids, and Metabolism (10 papers), Prostate Cancer Diagnosis and Treatment (4 papers), PARP inhibition in cancer therapy (3 papers), Lung Cancer Research Studies (2 papers), BRCA gene mutations in cancer (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (303 citations), Pulmonary and Respiratory Medicine (472 citations), Oncology (237 citations), Molecular Biology (341 citations) and Applied Microbiology and Biotechnology (7 citations). Ericka M. Ebot has collaborated with scholars based in United States, Sweden and Ireland. Frequent co-authors include Lorelei A. Mucci, Kathryn M. Wilson, Claire H. Pernar, Massimo Loda, Edward L. Giovannucci, Travis Gerke, Tamara L. Lotan, Jennifer R. Rider, Andreas Pettersson and Michelangelo Fiorentino. Their work appears in journals such as Cancer Epidemiology Biomarkers & Prevention, Clinical Cancer Research, European Urology, Carcinogenesis and Prostate Cancer and Prostatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.